| Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling PV Spirin, TD Lebedev, NN Orlova, AS Gornostaeva, MM Prokofjeva, ... Leukemia 28 (11), 2222-2228, 2014 | 78 | 2014 |
| The role of TAL1 in hematopoiesis and leukemogenesis ER Vagapova, PV Spirin, TD Lebedev, VS Prassolov Acta Naturae (англоязычная версия) 10 (1 (36)), 15-23, 2018 | 52 | 2018 |
| Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis ER Vagapova, TD Lebedev, VS Prassolov Scientific reports 11 (1), 11234, 2021 | 40 | 2021 |
| Two receptors, two isoforms, two cancers: comprehensive analysis of KIT and TrkA expression in neuroblastoma and acute myeloid leukemia TD Lebedev, ER Vagapova, VI Popenko, OG Leonova, PV Spirin, ... Frontiers in Oncology 9, 1046, 2019 | 36 | 2019 |
| Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas I Petrov, M Suntsova, E Ilnitskaya, S Roumiantsev, M Sorokin, A Garazha, ... Oncotarget 8 (48), 83768, 2017 | 32 | 2017 |
| Synergistic suppression of t (8; 21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors P Spirin, T Lebedev, N Orlova, A Morozov, N Poymenova, SE Dmitriev, ... Oncotarget 8 (34), 56991, 2017 | 26 | 2017 |
| Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes T Lebedev, E Vagapova, P Spirin, P Rubtsov, O Astashkova, A Mikheeva, ... Oncogene 40 (44), 6258-6272, 2021 | 24 | 2021 |
| Transfer and expression of small interfering RNAs in mammalian cells using lentiviral vectors TD Lebedev, PV Spirin, VS Prassolov Acta Naturae (англоязычная версия) 5 (2 (17)), 7-18, 2013 | 19 | 2013 |
| Identification of cell type–specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors TD Lebedev, ER Khabusheva, SR Mareeva, KA Ivanenko, AV Morozov, ... Journal of Biological Chemistry 298 (8), 2022 | 14 | 2022 |
| Modulation of activated oncogene c-kit expression with RNA-interference PV Spirin, NA Nikitenko, TD Lebedev, PM Rubtsov, C Stocking, ... Molecular Biology 45, 950-958, 2011 | 14 | 2011 |
| Lentiviral gene delivery to plasmolipin-expressing cells using Mus caroli endogenous retrovirus envelope protein MM Prokofjeva, GM Proshkina, TD Lebedev, AA Shulgin, PV Spirin, ... Biochimie 142, 226-233, 2017 | 12 | 2017 |
| Plasmolipin and its role in cell processes AA Shulgin, TD Lebedev, VS Prassolov, PV Spirin Molecular biology 55, 773-785, 2021 | 11 | 2021 |
| Selective inhibition of HDAC class I sensitizes leukemia and neuroblastoma cells to anticancer drugs E Vagapova, M Kozlov, T Lebedev, K Ivanenko, O Leonova, V Popenko, ... Biomedicines 9 (12), 1846, 2021 | 9 | 2021 |
| Key molecular mechanisms associated with cell malignant transformation in acute myeloid leukemia NN Orlova, TD Lebedev, PV Spirin, VS Prassolov Molecular Biology 50, 344-352, 2016 | 9 | 2016 |
| Cytotoxic marine alkaloid 3, 10-dibromofascaplysin induces apoptosis and synergizes with cytarabine resulting in leukemia cell death P Spirin, E Shyrokova, T Lebedev, E Vagapova, P Smirnova, ... Marine Drugs 19 (9), 489, 2021 | 8 | 2021 |
| High expression level of SP1, CSF1R, and PAK1 correlates with sensitivity of leukemia cells to the antibiotic mithramycin ER Vagapova, TD Lebedev, AD Tikhonova, BV Goikhman, KA Ivanenko, ... Molecular Biology 54, 458-463, 2020 | 8 | 2020 |
| Receptor tyrosine kinase KIT may regulate expression of genes involved in spontaneous regression of neuroblastoma TD Lebedev, PV Spirin, MV Suntsova, AV Ivanova, AA Buzdin, ... Molekuliarnaia Biologiia 49 (6), 1052-1055, 2015 | 8 | 2015 |
| Inhibition of non-receptor tyrosine kinase JAK2 reduces neuroblastoma cell growth and enhances the action of doxorubicin TD Lebedev, ER Vagapova, OO Astashkova, PV Spirin, VS Prassolov Molecular Biology 54, 256-261, 2020 | 7 | 2020 |
| Subtype of neuroblastoma cells with high KIT expression are dependent on KIT and its knockdown induces compensatory activation of pro-survival signaling T Lebedev, A Buzdin, E Khabusheva, P Spirin, M Suntsova, M Sorokin, ... International Journal of Molecular Sciences 23 (14), 7724, 2022 | 6 | 2022 |
| Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis NA Nikitenko, T Speiseder, P Groitl, PV Spirin, MM Prokofjeva, ... Biochimie 113, 10-16, 2015 | 6 | 2015 |
